NasdaqCM - Delayed Quote USD
Aprea Therapeutics, Inc. (APRE)
1.5450
+0.0750
+(5.10%)
At close: April 22 at 4:00:00 PM EDT
Insider Roster
Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.
Individual or Entity | Most Recent Transaction | Date | Shares Owned as of Transaction Date |
---|---|---|---|
DUEY MARC Director | Sale | Oct 18, 2024 | 234,253 |
GILAD OREN PH.D. Chief Executive Officer | Purchase | Apr 3, 2025 | 347,420 |
GRISSINGER MICHAEL J. Director | Stock Award(Grant) | Jun 20, 2024 | 1,844 |
HAMILL JOHN P Chief Financial Officer | Stock Award(Grant) | Mar 27, 2025 | 22,733 |
HENNEMAN JOHN BELL III Director | Stock Award(Grant) | Jun 20, 2024 | 9,184 |
MIRZA NADEEM Q. Officer | Stock Award(Grant) | May 1, 2024 | 6,730 |
PAMAKCU RIFAT Director | Stock Award(Grant) | Jun 20, 2024 | 18,509 |
PETERS RICHARD Director | Stock Award(Grant) | Jun 20, 2024 | 2,074 |
SEIZINGER BERND R. Director | Purchase | Oct 11, 2024 | 44,730 |
Related Tickers
048870.KQ Synergy Innovation Co., Ltd.
2,925.00
-2.99%
4DN.F Denali Therapeutics Inc.
12.88
+13.24%
ASBPW Aspire Biopharma Holdings, Inc.
0.0600
-24.91%
NRSNW NeuroSense Therapeutics Ltd.
0.2600
+30.00%
APTOF Aptose Biosciences Inc.
2.3100
-6.48%
XRTX.V XORTX Therapeutics Inc.
1.4400
+14.29%
ANL Adlai Nortye Ltd.
1.9996
-1.50%
INTS Intensity Therapeutics, Inc.
1.9100
+1.60%
CALC CalciMedica, Inc.
1.5200
-1.30%
XBIO Xenetic Biosciences, Inc.
2.4200
+0.83%